Didier Schrijvers
Overview
Explore the profile of Didier Schrijvers including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
403
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Diermen L, Lambrichts S, Berwouts J, Hebbrecht K, van den Ameele S, Coppens V, et al.
J Psychiatr Res
. 2025 Jan;
182:116-121.
PMID: 39809007
Introduction: Electroconvulsive therapy (ECT) is a widely recognized treatment for severe depressive disorders, particularly in cases of inadequate response to pharmacological interventions or when rapid symptom relief is essential. Although...
2.
Argyelan M, Deng Z, Ousdal O, Oltedal L, Angulo B, Baradits M, et al.
Mol Psychiatry
. 2023 Dec;
29(2):543.
PMID: 38052984
No abstract available.
3.
Argyelan M, Deng Z, Ousdal O, Oltedal L, Angulo B, Baradits M, et al.
Mol Psychiatry
. 2023 Nov;
29(2):229-237.
PMID: 37985787
Neurostimulation is a mainstream treatment option for major depression. Neuromodulation techniques apply repetitive magnetic or electrical stimulation to some neural target but significantly differ in their invasiveness, spatial selectivity, mechanism...
4.
Deng Z, Ousdal O, Oltedal L, Angulo B, Baradits M, Spitzberg A, et al.
Res Sq
. 2023 Jul;
PMID: 37398308
Neurostimulation is a mainstream treatment option for major depression. Neuromodulation techniques apply repetitive magnetic or electrical stimulation to some neural target but significantly differ in their invasiveness, spatial selectivity, mechanism...
5.
Belge J, Mulders P, van Diermen L, Sienaert P, Sabbe B, Abbott C, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2023 Jun;
127:110809.
PMID: 37331685
Background: Electroconvulsive therapy (ECT) remains the one of the most effective of biological antidepressant interventions. However, the exact neurobiological mechanisms underlying the efficacy of ECT remain unclear. A gap in...
6.
Culot C, Lauwers T, Fantini-Hauwel C, Madani Y, Schrijvers D, Morrens M, et al.
Conscious Cogn
. 2022 Dec;
107:103458.
PMID: 36580844
One aspect of metacognition is the ability to judge the accuracy of our own performance, even in the absence of external feedback, which is often measured using confidence ratings. Past...
7.
Hebbrecht K, Dejaeger M, Giltay E, Birkenhager T, Sabbe B, Verwijk E, et al.
J Psychiatr Res
. 2022 Dec;
158:41.
PMID: 36565543
No abstract available.
8.
Belge J, Mulders P, van Diermen L, Schrijvers D, Sabbe B, Sienaert P, et al.
Transl Psychiatry
. 2022 Dec;
12(1):517.
PMID: 36526624
ECT is proposed to exert a therapeutic effect on WM microstructure, but the limited power of previous studies made it difficult to highlight consistent patterns of change in diffusion metrics....
9.
Hebbrecht K, Dejaeger M, Giltay E, Birkenhager T, Sabbe B, Verwijk E, et al.
J Psychiatr Res
. 2022 Oct;
156:132-140.
PMID: 36252342
Cognitive function during an ECT care pathway is mainly investigated at the group level by analyzing mean cognitive test scores over time. However, there are important inter-individual differences, with some...
10.
Lambrichts S, Vansteelandt K, Hebbrecht K, Wagenmakers M, Oudega M, Obbels J, et al.
J Psychiatr Res
. 2022 Aug;
154:111-116.
PMID: 35933854
The risk of relapse following successful acute-phase treatment of late-life depression (LLD), including electroconvulsive therapy (ECT), is substantial. In order to improve reliable prediction of individuals' risk of relapse, we...